Of these latter four studies, one study addressed anti-D IgG dosing (100), one addressed anti-tumor necrosis factor for inflammatory bowel disease (101), and two modeled activities of CYP enzymes (102, 103). This evidence concerns the gene TNF and inflammatory bowel disease.